Meropenem-125 mg Injection | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Meropenem-125 mg Injection
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Injection
Class: Paediatric Carbapenem
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Meropenem-125 mg Injection Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Meropenem-125 mg Injection brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Meropenem-125 mg Injection is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Meropenem-125 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Neonatal sepsis
- Paediatric severe infections (MDR)
- Febrile neutropenia (paediatric)
- Paediatric meningitis (with cefotaxime)
Mechanism of Action
Meropenem is a carbapenem broad-spectrum beta-lactam — binds penicillin-binding proteins (PBP-2 and 3) inhibiting bacterial cell wall synthesis. Stable against most beta-lactamases including AmpC and ESBLs. Reserved for severe infections caused by multi-drug-resistant organisms.
Dosage & Administration
- Neonates: 20 mg/kg every 8–12 hours.
- Children: 10–20 mg/kg every 8 hours.
Side Effects
- GI upset, diarrhoea, hypersensitivity, seizures (less than imipenem), thrombocytosis, hepatic enzyme elevation.
Contraindications
- Hypersensitivity to carbapenems/penicillins (cross-reactivity ~1%), severe CNS disorders (seizure caution).
Storage
Store between 2–25 °C. Reconstituted: use immediately.
PCD Pharma Franchise for Meropenem-125 mg Injection
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: Vial + Water (Tray Pack)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Meropenem-125 mg Injection — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Meropenem-125 mg Injection, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Meropenem-125 mg Injection?
Trumac Healthcare is a WHO-GMP certified manufacturer of Meropenem-125 mg Injection in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Meropenem-125 mg Injection available for PCD pharma franchise on monopoly basis?
Yes. We offer Meropenem-125 mg Injection for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Meropenem-125 mg Injection?
Available pack sizes include: Vial + Water (Tray Pack).
What is the MRP / trade price for Meropenem-125 mg Injection?
MRPs range from ₹325 to ₹325 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Meropenem-125 mg Injection?